akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - nowotwory gruczołu krokowego, odpornego Łożysko - Środki przeciwnowotworowe - treatment of adult patients with prostate cancer.
ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroksysmal - selektywne leki immunosupresyjne - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroksysmal - leki immunosupresyjne - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
bicavera z 1,5% glukozą i wapniem 1,25 mmol/l roztwór do dializy otrzewnowej
fresenius medical care deutschland gmbh - sodu chlorek + wapnia chlorek dwuwodny + magnezu chlorek sześciowodny + glukoza jednowodna + sodu wodorowęglan - roztwór do dializy otrzewnowej
bicavera z 4,25% glukozą i wapniem 1,25 mmol/l roztwór do dializy otrzewnowej
fresenius medical care deutschland gmbh - sodu chlorek + wapnia chlorek dwuwodny + magnezu chlorek sześciowodny + glukoza jednowodna + sodu wodorowęglan - roztwór do dializy otrzewnowej
bicavera z 2,3% glukozą i wapniem 1,25 mmol/l roztwór do dializy otrzewnowej
fresenius medical care deutschland gmbh - sodu chlorek + wapnia chlorek dwuwodny + magnezu chlorek sześciowodny + glukoza jednowodna + sodu wodorowęglan - roztwór do dializy otrzewnowej
zoom 110 sc
sumitomo chemical agro europe s.a.s. rue de la voie lactée, parc d'affaires de crecy, f-69370 saint didier au mont d’or, francja - etoksazol - etoksazol - 110 g - akarycyd
mimic
nissan chemical europe sas parc d'affaire de crécy, rue de la voie lactée, 69370 saint-didier-au-mont-d'or, republika francuska - tebufenozyd - 240 g - insektycyd
ganifen
sumitomo chemical agro europe s.a.s. rue de la voie lactée, parc d'affaires de crecy, f-69370 saint didier au mont d’or (lyon), francja - bromukonazol - 300 g - fungicyd
sabarun
sumitomo chemical agro europe s.a.s. rue de la voie lactée, parc d'affaires de crecy, f-69370 saint didier au mont d’or (lyon), francja - bromukonazol - 300 g - fungicyd